- Last updated
IACM-Bulletin of December 19, 2021
🏷️ Science/Human — The use of cannabis is associated with a tendency for the normalisation of certain biomarkers in children with autism
Investigators of Cannformatics in San Francisco, USA, analysed potential cannabis-responsive biomarkers in saliva of 15 children with autism spectrum disorder (ASD) and 9 healthy children. Each child followed a unique regimen determined by their specific response over at least 1 year of treatment, which included THC-dominant cannabis (dosing range 0.05-50 mg per dose) in 40% of children and CBD-dominant cannabis (dosing range 7.5-200 mg per dose) in 60% of children. Samples from the ASD group were collected before treatment start and at time of maximal impact.